Rankings
▼
Calendar
RCKT Q2 2022 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$572M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$54M
Net Income
-$54M
EPS (Diluted)
$-0.83
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$42M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$432M
Total Liabilities
$44M
Stockholders' Equity
$388M
Cash & Equivalents
$188M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$54M
-$34M
-59.2%
Net Income
-$54M
-$35M
-57.6%
← FY 2022
All Quarters
Q3 2022 →